Indoleamine 2,3-dioxygenase activity and expression in patients with chronic lymphocytic leukemia

Clinical Lymphoma, Myeloma and Leukemia

Volumn 12, Issue 5, 2012, Pages 363-365

  Lindström, Vesa ^a,b   Aittoniemi, Janne ^c   Jylhävä, Juulia ^d   Eklund, Carita ^d   Hurme, Mikko ^c,d   Paavonen, Timo ^d   Oja, Simo S ^b   Itälä Remes, Maija ^e   Sinisalo, Marjatta ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c FIMLAB LABORATORIES   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

B cell; Immunity; Kynurenine; Lymphoproliferative disease; Tryptophan

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; PNEUMOCOCCUS VACCINE; TRYPTOPHAN;

ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; KYNURENINE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LEUKOCYTES, MONONUCLEAR; TRYPTOPHAN;

EID: 84867419186     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2012.06.001     Document Type: Article

References (23)

1. N. Chiorazzi, K.R. Rai, M. Ferrarini Chronic lymphocytic leukemia N Engl J Med 352 2005 804 815
2. F. Caligaris-Cappio, T.J. Hamblin B-cell chronic lymphocytic leukemia: a bird of a different feather J Clin Oncol 17 1999 399 408
3. D. Messmer, G. Telusma, T. Wasil Dendritic cells from chronic lymphocytic leukemia patients are normal regardless of Ig V gene mutation status Mol Med 10 2004 96 103
4. M. Sinisalo, J. Aittoniemi, H. Käyhty Vaccination against infections in chronic lymphocytic leukemia Leuk Lymphoma 44 2003 649 652
5. M. Sinisalo, J. Vilpo, M. Itälä Antibody response to 7-valent conjugated pneumococcal vaccine in patients with chronic lymphocytic leukaemia Vaccine 26 2007 82 87
6. A.L. Mellor, D.H. Munn Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today 20 1999 469 473
7. V. Najfeld, J. Menninger, D. Muhleman Localization of indoleamine 2,3-dioxygenase gene (INDO) to chromosome 8p12->p11 by fluorescent in situ hybridization Cytogenet Cell Genet 64 1993 231 232
8. H.J. Ball, A. Sanchez-Perez, S. Weiser Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice Gene 396 2007 203 213
9. H.J. Ball, H.J. Yuasa, C.J. Austin Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway Int J Biochem Cell Biol 41 2009 467 471
10. D.H. Munn, A.L. Mellor Indoleamine 2,3-dioxygenase and tumor-induced tolerance J Clin Invest 117 2007 1147 1154
11. A.L. Mellor, D.H. Munn IDO expression by dendritic cells: tolerance and tryptophan catabolism Nat Rev Immunol 4 2004 762 774
12. D.J. Kahler, A.L. Mellor T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase Handb Exp Pharmacol 188 2009 165 196
13. B.A. Johnson 3rd, D.J. Kahler, B. Baban B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase Proc Natl Acad Sci U S A 107 2010 10644 10648
14. M. Hoshi, H. Ito, H. Fujigaki Indoleamine 2,3-dioxygenase is highly expressed in human adult T-cell leukemia/lymphoma and chemotherapy changes tryptophan catabolism in serum and reduced activity Leuk Res 33 2009 39 45
15. S. Corm, C. Berthon, M. Imbenotte Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients' sera by HPLC and is inducible by IFN-gamma Leuk Res 33 2009 490 494
16. J. Jylhävä, C. Eklund, M. Jylhä Expression profiling of immune-associated genes in peripheral blood mononuclear cells reveals baseline differences in co-stimulatory signalling between nonagenarians and younger controls: the vitality 90+ study Biogerontology 11 2010 671 677
17. M. Pertovaara, A. Raitala, T. Lehtimäki Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality Mech Ageing Dev 127 2006 497 499
18. M. Cavia-Saiz, P. Muñiz, R. De Santiago Changes in the levels of thioredoxin and indoleamine-2,3-dioxygenase activity in plasma of patients with colorectal cancer treated with chemotherapy Biochem Cell Biol 90 2012 173 178
19. S.H. Sim, Y.O. Ahn, J. Yoon Influence of chemotherapy on nitric oxide synthase, indole-amine-2,3-dioxygenase and CD124 expression in granulocytes and monocytes of non-small cell lung cancer Cancer Sci 103 2012 155 160
20. P. Van Loo, T. Tousseyn, V. Vanhentenrijk T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response Haematologica 95 2010 440 448
21. M. Sioud New insights into mesenchymal stromal cell-mediated T-cell suppression through galectins Scand J Immunol 73 2011 79 84
22. M.J. Park, S.Y. Min, K.S. Park Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+regulatory T cells in Peyer′s patches in an orally tolerized, collagen-induced arthritis mouse model Arthritis Res Ther 10 2008 R11 Epub 2008 Jan 25
23. G. D'Arena, L. Laurenti, M.M. Minervini Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease Leuk Res 35 2011 363 368